ASF1B and cancer: Through molecular immune subtyping, we further observe significant differences in ASF1B expression levels across C1(wound healing), C1(IFN-γ dominant), C3(inflammatory), C4 (lymphocyte deplete), C5(immunologically quiet), and C6 (TGF-β dominant) subtypes for most analyzed cancers (Supplementary Figure 2).